{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T13:38:39Z","timestamp":1789047519416,"version":"build-2803163510"},"reference-count":50,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.ijrobp.2020.12.041","type":"journal-article","created":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T04:29:19Z","timestamp":1610080159000},"page":"596-608","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Estimates of Alpha\/Beta (\u03b1\/\u03b2) Ratios for Individual Late Rectal Toxicity Endpoints: An Analysis of the CHHiP Trial"],"prefix":"10.1016","volume":"110","author":[{"given":"Douglas H.","family":"Brand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah C.","family":"Br\u00fcningk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Wilkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Naismith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Syndikus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P.","family":"Dearnaley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison C.","family":"Tree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"van As","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Gulliford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2020.12.041_bib1","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S1470-2045(16)30102-4","article-title":"Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial","volume":"17","author":"Dearnaley","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2020.12.041_bib2","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1200\/JCO.2016.71.7397","article-title":"Randomized trial of a hypofractionated radiation regimen for the treatment of localized prostate cancer","volume":"35","author":"Catton","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2020.12.041_bib3","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1200\/JCO.2016.67.0448","article-title":"Randomized phase III noninferiority study comparing two radiotherapy fractionation schedules in patients with low-risk prostate cancer","volume":"34","author":"Lee","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2020.12.041_bib4","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/S1470-2045(16)30070-5","article-title":"Hypofractionated versus conventionally fractionated radiotherapy for patients with localised prostate cancer (HYPRO): Final efficacy results from a randomised, multicentre, open-label, phase 3 trial","volume":"17","author":"Incrocci","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2020.12.041_bib5","doi-asserted-by":"crossref","first-page":"e181","DOI":"10.1016\/j.ijrobp.2012.03.065","article-title":"Mean absorbed dose to the anal-sphincter region and fecal leakage among irradiated prostate cancer survivors","volume":"84","author":"Alsadius","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2020.12.041_bib6","doi-asserted-by":"crossref","first-page":"5139","DOI":"10.1088\/0031-9155\/54\/17\/005","article-title":"Using dose-surface maps to predict radiation-induced rectal bleeding: a neural network approach","volume":"54","author":"Buettner","year":"2009","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ijrobp.2020.12.041_bib7","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.radonc.2011.10.022","article-title":"Parameters for the Lyman Kutcher Burman (LKB) model of Normal Tissue Complication Probability (NTCP) for specific rectal complications observed in clinical practise","volume":"102","author":"Gulliford","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2020.12.041_bib8","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.radonc.2014.01.007","article-title":"Dose to the inferior rectum is strongly associated with patient reported bowel quality of life after radiation therapy for prostate cancer","volume":"110","author":"Stenmark","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2020.12.041_bib9","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.3109\/0284186X.2015.1063779","article-title":"Relationships between dose to the gastro-intestinal tract and patient-reported symptom domains after radiotherapy for localized prostate cancer","volume":"54","author":"Thor","year":"2015","journal-title":"Acta Oncol (Madr)"},{"key":"10.1016\/j.ijrobp.2020.12.041_bib10","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.radonc.2016.04.005","article-title":"Normal tissue complication probability (NTCP) models for late rectal bleeding, stool frequency and fecal incontinence after radiotherapy in prostate cancer NTCP models for anorectal side effects patients","volume":"119","author":"Schaake","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2020.12.041_bib11","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/j.ejmp.2016.09.018","article-title":"Modelling late stool frequency and rectal pain after radical radiotherapy in prostate cancer patients: Results from a large pooled population","volume":"32","author":"Cicchetti","year":"2016","journal-title":"Phys Medica"},{"key":"10.1016\/j.ijrobp.2020.12.041_bib12","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1259\/bjr\/31372149","article-title":"21 Years of biologically effective dose","volume":"83","author":"Fowler","year":"2010","journal-title":"Br J Radiol"},{"key":"10.1016\/j.ijrobp.2020.12.041_bib13","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.ijrobp.2009.12.045","article-title":"Acute and late toxicity in a randomized trial of conventional versus hypofractionated three-dimensional conformal radiotherapy for prostate cancer","volume":"79","author":"Arcangeli","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2020.12.041_bib14","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.radonc.2019.02.014","article-title":"Tolerance doses for late adverse events after hypofractionated radiotherapy for prostate cancer on trial NRG Oncology\/RTOG 0415","volume":"135","author":"Thor","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2020.12.041_bib15","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.ijrobp.2014.11.015","article-title":"Gastrointestinal dose-histogram effects in the context of dose-volume-constrained prostate radiation therapy: Analysis of data from the radar prostate radiation therapy trial","volume":"91","author":"Ebert","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2020.12.041_bib16","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s13014-016-0719-2","article-title":"Prostate external beam radiotherapy combined with high-dose-rate brachytherapy: Dose-volume parameters from deformably-registered plans correlate with late gastrointestinal complications","volume":"11","author":"Moulton","year":"2016","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2020.12.041_bib17","doi-asserted-by":"crossref","first-page":"e211","DOI":"10.1016\/j.ijrobp.2011.03.041","article-title":"Rectal bleeding after high-dose-rate brachytherapy combined with hypofractionated external-beam radiotherapy for localized prostate cancer: The relationship between dose-volume histogram parameters and the occurrence rate","volume":"82","author":"Okamoto","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2020.12.041_bib18","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.ijrobp.2004.04.014","article-title":"Fractionation and late rectal toxicity","volume":"60","author":"Brenner","year":"2004","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2020.12.041_bib19","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/1756-9966-28-117","article-title":"Modeling of alpha\/beta for late rectal toxicity from a randomized phase II study: Conventional versus hypofractionated scheme for localized prostate cancer","volume":"28","author":"Marzi","year":"2009","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2020.12.041_bib20","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.ijrobp.2010.11.080","article-title":"Estimation of \u03b1\/\u03b2 for late rectal toxicity based on RTOG 94-06","volume":"81","author":"Tucker","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2020.12.041_bib21","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1016\/S0167-8140(15)31079-3","article-title":"PO-0961: Estimation of a\/\u03b2 ratio for late rectal toxicity from localized prostate cancer irradiation","volume":"111","author":"Zhu","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2020.12.041_bib22","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.ijrobp.2004.12.087","article-title":"Gastrointestinal symptoms after pelvic radiotherapy: Role for the gastroenterologist?","volume":"62","author":"Andreyev","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2020.12.041_bib23","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0360-3016(01)02290-8","article-title":"Linear-quadratic alpha\/beta values for normal tissue injury dose-responses from acoustic neuroma and arteriovenous malformation radiosurgery","volume":"51","author":"Flickinger","year":"2001","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2020.12.041_bib24","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1470-2045(11)70293-5","article-title":"Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: Preliminary safety results from the CHHiP randomised controlled trial","volume":"13","author":"Dearnaley","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2020.12.041_bib25","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/S1470-2045(15)00280-6","article-title":"Hypofractionated radiotherapy versus conventionally fractionated radiotherapy for patients with intermediate-risk localised prostate cancer: 2-year patient-reported outcomes of the randomised, non-inferiority, phase 3 CHHiP trial","volume":"16","author":"Wilkins","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2020.12.041_bib26","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/0360-3016(95)00060-C","article-title":"Toxicity criteria of the radiation therapy oncology group (RTOG) and the european organization for research and treatment of cancer (EORTC)","volume":"3","author":"Cox","year":"1995","journal-title":"Pergamon Int J Radi Ati Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2020.12.041_bib27","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.radonc.2007.02.014","article-title":"The early toxicity of escalated versus standard dose conformal radiotherapy with neo-adjuvant androgen suppression for patients with localised prostate cancer: Results from the MRC RT01 trial (ISRCTN47772397)","volume":"83","author":"Dearnaley","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2020.12.041_bib28","first-page":"1","article-title":"LENT SOMA tables","volume":"35","year":"1995","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2020.12.041_bib29","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.ijrobp.2009.02.025","article-title":"Dose-volume constraints to reduce rectal side effects from prostate radiotherapy: Evidence from MRC RT01 Trial ISRCTN 47772397","volume":"76","author":"Gulliford","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2020.12.041_bib30","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ijrobp.2012.02.021","article-title":"Incorporating single nucleotide polymorphisms into the Lyman model to improve prediction of radiation pneumonitis","volume":"85","author":"Tucker","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2020.12.041_bib31","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1118\/1.598063","article-title":"Reporting and analyzing dose distributions: A concept of equivalent uniform dose","volume":"24","author":"Niemierko","year":"1997","journal-title":"Med Phys"},{"key":"10.1016\/j.ijrobp.2020.12.041_bib32","first-page":"548","article-title":"Improvements on cross-validation: The 632+ bootstrap method","volume":"92","author":"Efron","year":"1997","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.ijrobp.2020.12.041_bib33","doi-asserted-by":"crossref","first-page":"E122","DOI":"10.1016\/j.ijrobp.2017.06.888","article-title":"The history of the Lyman-Kutcher-Burman model and its application to the alpha-beta ratio modeling using modern statistics","volume":"99","author":"Dong","year":"2017","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2020.12.041_bib34","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1137\/S1052623496303470","article-title":"Convergence properties of the Nelder-Mead simplex method in low dimensions","volume":"9","author":"Lagarias","year":"1998","journal-title":"SIAM J Optim"},{"key":"10.1016\/j.ijrobp.2020.12.041_bib35","series-title":"An Introduction to Statistical Learning: With Applications in R","author":"James","year":"2013"},{"key":"10.1016\/j.ijrobp.2020.12.041_bib36","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1080\/01621459.1983.10477973","article-title":"Estimating the error rate of a prediction rule: Improvement on cross-validation","volume":"78","author":"Efron","year":"1983","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.ijrobp.2020.12.041_bib37","series-title":"Teoria statistica delle classi e calcolo delle probabilit\u00e0","author":"Bonferroni","year":"1936"},{"key":"10.1016\/j.ijrobp.2020.12.041_bib38","author":"D\u2019Errico"},{"key":"10.1016\/j.ijrobp.2020.12.041_bib39","doi-asserted-by":"crossref","first-page":"6072","DOI":"10.1002\/sim.3427","article-title":"Meta-analysis of skewed data: Combining results reported on log-transformed or raw scales","volume":"27","author":"Higgins","year":"2008","journal-title":"Stat Med"},{"key":"10.1016\/j.ijrobp.2020.12.041_bib40","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijrobp.2006.03.034","article-title":"Rectal bleeding, fecal incontinence, and high stool frequency after conformal radiotherapy for prostate cancer: Normal tissue complication probability modeling","volume":"66","author":"Peeters","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2020.12.041_bib41","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.ijrobp.2011.03.056","article-title":"The benefits of including clinical factors in rectal normal tissue complication probability modeling after radiotherapy for prostate cancer","volume":"82","author":"Defraene","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2020.12.041_bib42","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.radonc.2004.08.013","article-title":"Fitting late rectal bleeding data using different NTCP models: Results from an Italian multi-centric study (AIROPROS0101)","volume":"73","author":"Rancati","year":"2004","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2020.12.041_bib43","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ijrobp.2009.03.078","article-title":"Radiation dose-volume effects in radiation-induced rectal injury","volume":"76","author":"Michalski","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2020.12.041_bib44","series-title":"Modelling Radiotherapy Side Effects","author":"Rancati","year":"2019"},{"key":"10.1016\/j.ijrobp.2020.12.041_bib45","doi-asserted-by":"crossref","first-page":"20140343","DOI":"10.1259\/bjr.20140343","article-title":"Random variation in rectal position during radiotherapy for prostate cancer is two to three times greater than that predicted from prostate motion","volume":"87","author":"Scaife","year":"2014","journal-title":"Br J Radiol"},{"key":"10.1016\/j.ijrobp.2020.12.041_bib46","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0090-4295(00)00858-X","article-title":"Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life\u00a0in men with prostate cancer","volume":"56","author":"Wei","year":"2000","journal-title":"Urology"},{"key":"10.1016\/j.ijrobp.2020.12.041_bib47","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/S1470-2045(19)30569-8","article-title":"Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial","volume":"20","author":"Brand","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2020.12.041_bib48","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0140-6736(19)31131-6","article-title":"Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-Year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial","volume":"394","author":"Widmark","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2020.12.041_bib49","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMoa1606221","article-title":"Patient-reported outcomes after monitoring, surgery, or radiotherapy for prostate cancer","volume":"375","author":"Donovan","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2020.12.041_bib50","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ijrobp.2013.07.022","article-title":"The tumor radiobiology of SRS and SBRT: Are more than the 5 Rs involved?","volume":"88","author":"Brown","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301620347374?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301620347374?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T09:53:09Z","timestamp":1759744389000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301620347374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S0360301620347374"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2020.12.041","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Estimates of Alpha\/Beta (\u03b1\/\u03b2) Ratios for Individual Late Rectal Toxicity Endpoints: An Analysis of the CHHiP Trial","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2020.12.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}